Effects of Task-Oriented Intervention in Children With Developmental Coordination Disorder
Launched by RIPHAH INTERNATIONAL UNIVERSITY · Dec 12, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how a special type of therapy, called task-oriented intervention, can help children with Developmental Coordination Disorder (DCD), which is also known as dyspraxia. DCD affects a child's ability to move and coordinate their body, making everyday activities like writing, tying shoelaces, and playing sports more challenging. The goal of the study is to see if this therapy can improve skills like hand-eye coordination and overall movement in children aged 4 to 12 who have been diagnosed with DCD.
To participate in the trial, children must be between 4 and 12 years old and have a specific score on a questionnaire that measures coordination difficulties. They should be able to understand and follow simple instructions. However, children with certain medical issues, like severe seizures or significant visual or hearing problems, won't be able to join. Participants in the trial can expect to engage in fun, goal-directed activities designed to help improve their coordination skills, which could make everyday tasks easier and improve their quality of life.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Developmental coordination disorder children aged 4 to 12 years old.
- • Have a total score of 15-57 on the Developmental Coordination Disorder Questionnaire2007.
- • Children had to be able to understand and follow instructions.
- • Boys and girls both are included
- Exclusion Criteria:
- • Children with unstable seizures will be excluded.
- • DCD children with any congenital cardio-respiratory condition, congenital musculoskeletal condition.
- • DCD children with severe visual and/or hearing disability preventing them from completing exercises prescribed by either program.
- • Children with behavioral difficulty making them unable to complete exercises prescribed by either program
About Riphah International University
Riphah International University is a leading educational institution based in Pakistan, dedicated to advancing healthcare and medical research through innovative clinical trials. With a commitment to excellence in research and education, Riphah emphasizes ethical standards and scientific integrity in its clinical studies. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to enhance patient outcomes and contribute to the global body of medical knowledge. Through its robust research programs, Riphah International University aims to foster a culture of inquiry and improve healthcare delivery both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lahore, Punjab, Pakistan
Patients applied
Trial Officials
Mah Noor Fatima, MS*
Principal Investigator
Riphah International University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported